{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:11:59Z","timestamp":1791191519997,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.braindev.2009.04.005","type":"journal-article","created":{"date-parts":[[2009,5,10]],"date-time":"2009-05-10T08:44:55Z","timestamp":1241945095000},"page":"425-427","source":"Crossref","is-referenced-by-count":19,"title":["Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome"],"prefix":"10.1016","volume":"32","author":[{"given":"Augusto","family":"Pasini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"D\u2019Agati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Casarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2009.04.005_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ajmg.c.30155","article-title":"22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay","volume":"145C","author":"Cusmano-Ozog","year":"2007","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.braindev.2009.04.005_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1172-3-14","article-title":"Deletion 22q13.3 syndrome","volume":"3","author":"Phelan","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.braindev.2009.04.005_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C","article-title":"22q13 deletion syndrome","volume":"101","author":"Phelan","year":"2001","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.braindev.2009.04.005_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/jmg.37.1.58","article-title":"Cryptic subtelomeric translocations in the 22q13 deletion syndrome","volume":"37","author":"Praphanphoj","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.braindev.2009.04.005_bib5","doi-asserted-by":"crossref","unstructured":"Guy W. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, and Welfare. Washington DC: Publication ADM; 1976. p. 534\u20137.","DOI":"10.1037\/e591322011-001"},{"issue":"5","key":"10.1016\/j.braindev.2009.04.005_bib6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1471-4159.2002.00931.x","article-title":"ProSAP\/Shank proteins \u2013 a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease","volume":"81","author":"Boeckers","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.braindev.2009.04.005_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmg.40.8.575","article-title":"Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3\/PROSAP2 in the major neurological symptoms","volume":"40","author":"Wilson","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.braindev.2009.04.005_bib8","doi-asserted-by":"crossref","unstructured":"Laruelle M, Frankle WG, Narendran R, Kegeles LS, Abi-Dargham A. Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin Ther 2005;27(Suppl. A):S16\u201324.","DOI":"10.1016\/j.clinthera.2005.07.017"},{"key":"10.1016\/j.braindev.2009.04.005_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1523\/JNEUROSCI.22-01-00294.2002","article-title":"Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis","volume":"22","author":"West","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.braindev.2009.04.005_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.euroneuro.2008.08.010","article-title":"Effects of risperidone on glutamate receptor subtypes in developing rat brain","volume":"19","author":"Choi","year":"2008","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760409001338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760409001338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:32Z","timestamp":1558310432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760409001338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0387760409001338"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2009.04.005","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}